dr-reddy - Latest News on dr-reddy | Read Breaking News on Zee News
Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Last Updated: Wednesday, April 16, 2014, 14:46

The company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone.

Dr Reddy's eyes fresh foray into Japanese market

Last Updated: Sunday, March 30, 2014, 16:13

After shrugging off its proposed joint venture with Fujifilm which was a non-starter, Dr Reddy's Laboratories Limited is back on the drawing board and is keen to make a fresh foray into the Japanese market.

Dr Reddy's launches generic cholesterol-lowering drug in US

Last Updated: Thursday, March 27, 2014, 13:55

The company's product is the generic equivalent of Pfizer Inc's Caduet tablets.

Dr Reddy's Lab recalls 58,656 bottles of Lansoprazole in US

Last Updated: Thursday, March 13, 2014, 14:20

Dr Reddy's Laboratories has recalled 58,656 bottles of its heartburn drug Lansoprazole in the United States due to a microbial contamination.

Dr Reddy's launches antibiotic drug in US market

Last Updated: Wednesday, March 05, 2014, 14:53

Dr Reddy's Laboratories Ltd has launched Moxifloxacin Hydrochloride tablets in the US market for the treatment of a wide range of diseases, including pneumonia, bronchitis and skin infections.

Dr Reddy's share surges 2%; m-cap swells by Rs 1,512 cr

Last Updated: Wednesday, February 26, 2014, 19:33

Shares of Dr Reddy's Ltd touched a record high and settled with gains of nearly 2 percent on the BSE after pharma major launched Sumatriptan Injection USP in the US.

Dr Reddy's Q3 profit jumps 70.21% to Rs 618.42 cr

Last Updated: Tuesday, February 11, 2014, 15:17

It had posted a profit of Rs 363.31 crore in the same period of the previous year.

24 SEZ developers seek more time for projects; 3 to surrender

Last Updated: Thursday, January 16, 2014, 16:31

As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.

Indian cos in FDA's first list for generic Aciphex tablets

Last Updated: Sunday, November 10, 2013, 13:14

In a decision that will cheer the domestic pharma industry, Indian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic version of Aciphex, used to treat gastroesophageal reflux disease (GERD).

Dr Reddy's to launch anti-blood clot drug in Canada

Last Updated: Monday, November 04, 2013, 17:41

Country's largest drug maker Dr Reddy's Laboratories is set to take its complex generic drug Fondaparinux sodium injection to Canada and two other emerging markets.

Dr Reddy's Lab Q2 profit up 69% at Rs 690 crore

Last Updated: Thursday, October 31, 2013, 15:54

Drug major Dr Reddy's Laboratories today reported a 69.41 percent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.

Reddy's would infringe on Lunesta's patent: US court of appeal

Last Updated: Friday, September 27, 2013, 12:21

United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta.